类风湿关节炎循环与滑膜免疫复合物的Fcγ受体IIIA生物活性
该研究采用新型报告细胞检测法分析类风湿关节炎(RA)患者血清和滑液中的可溶性免疫复合物(sICs)对Fcγ受体IIIA(CD16)的激活能力,并在验证队列中与银屑病关节炎(PsA)、系统性红斑狼疮(SLE)及健康对照比较。结果显示RA患者循环sICs具有CD16激活能力且出现频率显著增高,滑液sICs生物活性高并与血清自身抗体水平相关;SLE循环sICs检出频率高于RA。
要点
- RA患者血清和滑液中存在可激活CD16的sICs
- 滑液sICs生物活性高且与血清自身抗体水平相关
- SLE循环sICs检出频率高于RA,CD16生物活性存在明显供者间差异
核心结论
- RA的特征是存在循环和滑膜sICs,这些sICs能够结合并激活CD16。
研究设计与样本
- 探索性队列纳入50例RA患者血清,验证队列纳入106例RA、20例PsA、22例SLE患者和31名健康对照的血清,另分析26份滑液样本(包括配对的血清/滑液样本),采用新型报告细胞检测法检测sICs对CD16的激活能力。
主要发现
- 首次使用可靠且灵敏的功能性检测法证实RA血清中存在sICs。
- sICs具有激活CD16的内在能力,可在滑液和血液中检出。
- 在低实验稀释度下,部分健康人和PsA患者也可检出循环sICs,但RA中生物活性循环sICs的频率显著增高。
- 循环sICs生物活性低且与临床参数不相关,而滑膜sICs生物活性高并与血清自身抗体水平相关。
- 受试者工作特征曲线提示滑液中sICs生物活性可用于区分免疫复合物相关关节炎与非相关类型关节炎,且循环sICs在SLE中比在RA中更常见。
关键数值与推荐
- 采用新型报告细胞检测法分析sICs对CD16的激活能力。
- 滑液sICs生物活性与血清自身抗体水平相关。
- 受试者工作特征曲线提示滑液sICs生物活性可区分免疫复合物相关关节炎与非相关类型关节炎。
临床怎么用
- 原文未据此给出推荐。
局限性
- 循环sICs生物活性低且与临床参数不相关。
- CD16生物活性表现出强烈的供者依赖性差异,尤其在SLE中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Previous technical limitations prevented the proof of Fcγ-receptor (FcγR)-activation by soluble immune complexes (sICs) in patients. FcγRIIIa (CD16) is a risk factor in rheumatoid arthritis (RA). We aimed at determining the presence of CD16-activating sICs in RA and control diseases. METHODS: Sera from an exploratory cohort (n=50 patients with RA) and a validation cohort (n=106 patients with RA, 20 patients with psoriasis arthritis (PsA), 22 patients with systemic lupus erythematosus (SLE) and 31 healthy controls) were analysed using a new reporter cell assay. Additionally, 26 synovial fluid samples were analysed, including paired serum/synovial samples. RESULTS: For the first time using a reliable and sensitive functional assay, the presence of sICs in RA sera was confirmed. sICs possess an intrinsic capacity to activate CD16 and can be found in both synovial fluid and in blood. In low experimental dilutions, circulating sICs were also detected in a subset of healthy people and in PsA. However, we report a significantly increased frequency of bioactive circulating sICs in RA. While the bioactivity of circulating sICs was low and did not correlate with clinical parameters, synovial sICs were highly bioactive and correlated with serum autoantibody levels. Receiver operator curves indicated that sICs bioactivity in synovial fluid could be used to discriminate immune complex-associated arthritis from non-associated forms. Finally, circulating sICs were more frequently found in SLE than in RA. The degree of CD16 bioactivity showed strong donor-dependent differences, especially in SLE. CONCLUSIONS: RA is characterised by the presence of circulating and synovial sICs that can engage and activate CD16.
引用
- Andreeva I, Kolb P, Rodon L, et al. Fcγ-receptor-IIIA bioactivity of circulating and synovial immune complexes in rheumatoid arthritis. RMD Open. 2024. PMID: 39209371. doi:10.1136/rmdopen-2024-004190
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。